Lazard Capital Upgrades Aegerion Pharmaceuticals (AEGR) to Buy

February 11, 2013 6:51 AM EST
Get Alerts AEGR Hot Sheet
Price: $1.97 --0%

Rating Summary:
    11 Buy, 4 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 12 | New: 43
Trade AEGR Now!
Join SI Premium – FREE
Lazard Capital upgraded Aegerion Pharmaceuticals (NASDAQ: AEGR) from Hold to Buy.

For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.

Shares of Aegerion Pharmaceuticals closed at $26.51 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment